Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Castle Biosciences, Inc. (CSTL) had Receiveable Turnover of 5.74 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$219.79M |
|
$-57.47M |
|
$44.98M |
|
$174.81M |
|
$287.76M |
|
$-67.98M |
|
$10.61M |
|
$-57.37M |
|
$-57.37M |
|
$-57.47M |
|
$-57.47M |
|
$-57.47M |
|
$-57.47M |
|
$-67.98M |
|
$-61.14M |
|
26.80M |
|
26.80M |
|
$-2.14 |
|
$-2.14 |
|
| Balance Sheet Financials | |
$295.63M |
|
$25.43M |
|
$157.71M |
|
$453.34M |
|
$47.67M |
|
-- |
|
$14.40M |
|
$62.07M |
|
$391.27M |
|
$273.93M |
|
$391.27M |
|
27.41M |
|
| Cash Flow Statement Financials | |
$-5.63M |
|
$-16.18M |
|
$-2.30M |
|
$122.95M |
|
$98.84M |
|
$-24.11M |
|
$51.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
79.53% |
|
-30.93% |
|
-30.93% |
|
-27.82% |
|
-26.10% |
|
-26.15% |
|
$-19.23M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
5.66 |
|
|
Receiveable Turnover |
5.74 |
63.61 |
|
-14.69% |
|
-20.98% |
|
-12.68% |
|
-14.69% |
|
$14.27 |
|
$-0.72 |
|
$-0.21 |
|